Active Safety Surveillance of the Pfizer-BioNTech COVID-19 Vaccine in the United States Department of Defense Population Following Emergency Use Authorization First published 03/07/2023 Last updated 02/07/2024 EU PAS number:EUPAS50375 Study Finalised